Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Polanczyk, M. Lima, B. Horta, J. Biederman, L. Rohde (2007)
The worldwide prevalence of ADHD: a systematic review and metaregression analysis.The American journal of psychiatry, 164 6
A. Riley, C. Forrest, B. Starfield, G. Rebok, Judith Robertson, B. Green (2004)
The Parent Report Form of the CHIP–Child Edition: Reliability and ValidityMedical Care, 42
D. Michelson, D. Faries, J. Wernicke, D. Kelsey, Katherine Kendrick, F. Sallee, T. Spencer (2001)
Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.Pediatrics, 108 5
R. Barkley, M. Fischer, Lori Smallish, K. Fletcher (2002)
The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder.Journal of abnormal psychology, 111 2
Jihyung Hong, D. Novick, T. Treuer, W. Montgomery, V. Haynes, S. Wu, J. Haro (2013)
Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East AsiaPatient preference and adherence, 7
Jihyung Hong, D. Novick, T. Treuer, W. Montgomery, V. Haynes, S. Wu, J. Haro (2014)
Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East AsiaBMC Psychiatry, 14
F. Martényi, T. Treuer, S. Gau, S. Hong, M. Palaczky, J. Šuba, Mircea Tiberiu, P. Uhlíková, Tong Xu, S. Zoroğlu, K. Gadow, R. Walton, G. Harrison (2009)
Attention-deficit/hyperactivity disorder diagnosis, co-morbidities, treatment patterns, and quality of life in a pediatric population in central and eastern Europe and Asia.Journal of child and adolescent psychopharmacology, 19 4
Dr Harpin (2005)
The effect of ADHD on the life of an individual, their family, and community from preschool to adult lifeArchives of Disease in Childhood, 90
S. Mannuzza, R. Klein, Abrah Bessler, P. Malloy, Maria Lapadula (1998)
Adult psychiatric status of hyperactive boys grown up.The American journal of psychiatry, 155 4
Yishi Jiang, Xiaohua Ying, S. Kane, M. Mukhopadhyay, Xu Qian (2014)
Violence against doctors in ChinaThe Lancet, 384
T. Hesketh, Dan Wu, L. Mao, Nan Ma (2012)
Violence against doctors in ChinaBMJ : British Medical Journal, 345
N. Zavadenko, S. Suvorinova (2004)
[Therapeutic efficacy of nootropil different doses in attention deficit hyperactivity disorder].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 104 3
S. Kooij, S. Bejerot, A. Blackwell, H. Caci, M. Casas-Brugué, P. Carpentier, D. Edvinsson, J. Fayyad, K. Foeken, M. Fitzgerald, V. Gaillac, Y. Ginsberg, C. Henry, J. Krause, M. Lensing, I. Manor, H. Niederhofer, Carlos Nunes-Filipe, M. Ohlmeier, P. Oswald, S. Pallanti, A. Pehlivanidis, J. Ramos-Quiroga, M. Råstam, Doris Ryffel-Rawak, S. Stes, P. Asherson (2010)
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDBMC Psychiatry, 10
P. Rasmussen, C. Gillberg (2000)
Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study.Journal of the American Academy of Child and Adolescent Psychiatry, 39 11
M. Wolraich, L. Brown, Ronald Brown, G. DuPaul, Marian Earls, H. Feldman, T. Ganiats, Beth Kaplanek, Bruce Meyer, J. Perrin, K. Pierce, M. Reiff, M. Stein, S. Visser (2011)
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.Pediatrics, 128 5
F. Martényi, Yi Zheng, Yu-Shu Huang, Yong-Sik Lee, Richard Walton, G. Harrison, Tamas Treuer (2010)
A prospective observational study of attention-deficit hyperactivity disorder in Asia: baseline characteristics of symptom severity and treatment options in a paediatric population.East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan, 20 2
S. Lee, D. Song, Dongwon Shin, Ji Kim, Young Lee, Jun-Won Hwang, T. Park, K. Yook, Jong Lee, G. Bahn, Yuko Hirata, T. Goto, Y. Takita, Michihiro Takahashi, Sanghoon Lee, T. Treuer (2014)
Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention‐deficit hyperactivity disorderAsia‐Pacific Psychiatry, 6
K. Gajria, M. Lu, V. Sikirica, P. Greven, Y. Zhong, P. Qin, Jipan Xie (2014)
Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature reviewNeuropsychiatric Disease and Treatment, 10
Kai-Jing Ding, Yun-Fen Liu, Chuanyuan Kang, Rui-xiang Liu, Xue-rong Li, Shuai Wan (2013)
[Influential factors for methylphenidate treatment compliance in children with attention deficit hyperactivity disorder].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 15 5
(1976)
ECDEU Assessment Manual for Psychopharmacology, Revised, 1976. U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration
Yan Zhang, Chuanyuan Kang, Xing-rong Zhao, Xu Xuan, Kai-Jing Ding, Rui-xiang Liu, Yanjiao Wang, Run-Xu Yang, Xue-rong Li, Shuai Wan (2014)
[Effect of parent training in combination with methylphenidate treatment on family relationships for children with attention deficit/hyperactivity disorder].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 16 2
R. Dickson, Ellen Maki, Christopher Gibbins, Stephen Gutkin, A. Turgay, M. Weiss (2011)
Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studiesChild and Adolescent Psychiatry and Mental Health, 5
R. Kessler (2006)
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.The American journal of psychiatry, 163 4
E. Hart, B. Lahey, R. Loeber, B. Applegate, P. Frick (1995)
Developmental change in attention-deficit hyperactivity disorder in boys: A four-year longitudinal studyJournal of Abnormal Child Psychology, 23
T. Treuer, Q. Feng, D. Desaiah, M. Altın, S. Wu, A. El-Shafei, E. Serebryakova, M. Gado, D. Faries (2014)
Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention‐deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab EmiratesInternational Journal of Clinical Practice, 68
A. Riley, C. Forrest, G. Rebok, B. Starfield, B. Green, Judith Robertson, Phyllis Friello (2004)
The Child Report Form of the CHIP–Child Edition: Reliability and ValidityMedical Care, 42
J. Setyawan, A. Guerin, P. Hodgkins, G. Gauthier, M. Cloutier, E. Wu, M. Erder (2013)
Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medicationsJournal of Medical Economics, 16
M. Weiss, R. Tannock, C. Kratochvil, D. Dunn, J. Vélez-Borrás, C. Thomason, R. Tamura, D. Kelsey, L. Stevens, A. Allen (2005)
A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.Journal of the American Academy of Child and Adolescent Psychiatry, 44 7
T. Lancet (2012)
Ending violence against doctors in ChinaThe Lancet, 379
H. Kristensen, S. Torgersen (2006)
Social anxiety disorder in 11–12-year-old childrenEuropean Child & Adolescent Psychiatry, 15
Rana Ahmed, P. Aslani (2013)
Attention-deficit/hyperactivity disorder: an update on medication adherence and persistence in children, adolescents and adultsExpert Review of Pharmacoeconomics & Outcomes Research, 13
S. Mannuzza, R. Klein, Noreen Bonagura, P. Malloy, Tina Giampino, Kathy Addalli (1991)
Hyperactive boys almost grown up. V. Replication of psychiatric status.Archives of general psychiatry, 48 1
A. Riley, D. Coghill, C. Forrest, M. Lorenzo, Stephen Ralston, G. Spiel, Adore Group (2006)
Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child EditionEuropean Child & Adolescent Psychiatry, 15
(2013)
Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countriesDrugs in Context, 2013
T. Spencer, J. Heiligenstein, J. Biederman, D. Faries, C. Kratochvil, C. Conners, W. Potter (2002)
Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.The Journal of clinical psychiatry, 63 12
J. Biederman, M. Monuteaux, E. Mick, T. Spencer, T. Wilens, Julie Silva, L. Snyder, S. Faraone (2006)
Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up studyPsychological Medicine, 36
R. Barkley, D. Guevremont, A. Anastopoulos, G. DuPaul, Tern Shelton (1993)
Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey.Pediatrics, 92 2
(2002)
Child Symptom Inventory 4: Screening and Norms Manual, Checkmate Plus
ADHD, atomoxetine, China, clinical outcome, Introduction: This post-hoc analysis was to investigate the impact of treat- treatment discontinuation ment discontinuation on clinical outcomes in patients with attention- deficit/hyperactivity disorder (ADHD). Author Contributions Methods: Data are from a 12-month, observational, multinational study All authors were involved in drafting, critical that included outpatients aged 6–17 years who were diagnosed with revision, and approval of the manuscript. ADHD and treated with atomoxetine, methylphenidate, or nootropic Funding: This trial was funded by Eli Lilly and agents. Treatment effectiveness and proportions of patients who discon- Company and/or any of its subsidiaries, tinued treatment were compared between China and the other non- Indianapolis, IN, USA. Trial Registration: Observational study, Western countries/regions combined. Propensity score matching was used therefore no registration. to further estimate the association between treatment discontinuation and effectiveness. Correspondence Results: Of the 546 patients who entered the study, 337 patients had Tamas Treuer MD PhD, Neuroscience Research, complete data and were included in the analyses. Compared with the Eli Lilly and Company, H-1075 Budapest, other countries/regions, China subgroup had a higher treatment Madách Imre u. 13-14, Hungary. discontinuation rate (odds ratio = 25.80; P < 0.0001) and poorer treatment Tel: +36-1-328-5127 effectiveness: least-squares
Asia-Pacific Psychiatry – Wiley
Published: Mar 1, 2017
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.